Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Committee for Medicinal Products for Human Use (CHMP)
The Committee is responsible for preparing the European Medicines Agency's (EMA) opinions on all questions concerning medicinal products for human use, in accordance with Regulation (EC) No 726/2004.
See also:
Committee for Medicinal Products for Human Use (CHMP)
Related terms
Disease mongering, Price maker, Screening trials, Effectiveness, European Federation of Pharmaceutical Industries (EFPIA), Phase II trials, Prevention trials, Recruitment status, Dose-ranging trial, Drop out, Disease awareness marketing, Commission on Human Medicines (CHM), Informed consent, Advertising research, Placebo effect,
COVID-19 Updates and Daily News
Featured jobs
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Regeneron says antibody for COVID-19 could be ready this year
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July
- Impetus Digital Fireside Chat with Susanne Somerville of Chronicled
- Impetus Digital Fireside Chat with Bechara Saab of Mobio Interactive
- FDA delays review of Novartis’ MS drug ofatumumab
- Sanofi makes ‘best-in-class’ claim for Sarclisa in myeloma
- Q&A: Kay Wesley
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Quick links
Infographics
